DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
Ming Zhong, Huiqiang Wang, Linlin Ma, Haiyan Yan, Shuo Wu, Zhengyi Gu, Yuhuan Li, Ming Zhong, Huiqiang Wang, Linlin Ma, Haiyan Yan, Shuo Wu, Zhengyi Gu, Yuhuan Li
Abstract
Background: As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, development of new drugs is urgently required. Flavonoids extracted from Artemisia rupestris L. have an inhibitory effect on virus infections. Despite this fact, the antiviral properties of 6-demethoxy-4'-O-methylcapillarisin (DMO-CAP), one of such flavonoids, against the influenza virus have not been reported. Thus, the aim of this study is to investigate the anti-IAV virus efficacy and antiviral mechanism of DMO-CAP.
Methods: The inhibitory activity of DMO-CAP against IAV was detected in vitro using viral titers by Western blot analysis, qRT-PCR, and immunofluorescence assays. The mechanism of DMO-CAP against influenza virus was analyzed by Western blot analysis, qRT-PCR, and luciferase assay.
Results: DMO-CAP exhibits broad spectrum of antiviral activities against IAV in vitro. Mechanistically, DMO-CAP treatment induced the phosphorylation of p38 mitogen-activated protein kinase (MAPK), JNK MAPK, and ERK MAPK, which led to the activation of Nrf2/heme oxygenase-1 (HO-1) pathway. Then, the up-regulation of HO-1 expression activated the IFN response and induced the expression of IFN-stimulated genes, thereby leading to efficient anti-IAV effects.
Conclusions: DMO-CAP inhibited IAV replication by activating HO-1-mediated IFN response. DMO-CAP may be a potential agent or supplement against IAV infection.
Conflict of interest statement
Ethics approval and consent to participateNot applicable.
Consent for publicationNot applicable.
Competing interestsThe authors have declared that they have no competing interests.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- Lansbury LE, Brown CS, Nguyen JS. Influenza in long-term care facilities. Influenza Other Respir Viruses. 2017;11:356–366. doi: 10.1111/irv.12464.
- World Health Organization. Influenza (Seasonal) [Internet; cited 2018 Oct]. []. Accessed 6 Nov 2018.
- Vanderven HA, Liu L, Fernanda ASB, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang XY, Xu JQ, Stephen JK. Functional antibodies in humans with severe H7N9 and seasonal influenza. JCI insight. 2017;2:e92750. doi: 10.1172/jci.insight.92750.
- Wong SS, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev. 2013;26:476–492. doi: 10.1128/CMR.00097-12.
- Erhard MS, Pieter F, Charles B, Albert O. Influenza virus resistance to antiviral therapy. Adv Pharmacol. 2013;67:217–246. doi: 10.1016/B978-0-12-405880-4.00006-8.
- Koszalka P, Tilmanis D, Hurt AC. Influenza antivirals currently in late-phase clinical trial. Influenza Other Respir Viruses. 2017;11:240–246. doi: 10.1111/irv.12446.
- Hayden F. Baloxavir Marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379:913–923. doi: 10.1056/NEJMoa1716197.
- Ison M, CAPSTONE-2 trial. Infectious Disease Week; 2018 Oct 3-7; San Francisco. CA, USA. []. Accessed 3-7 Oct 2018.
- Clark AM, DeDiego ML, Anderson CS, Wang J, Yang H, Nogales A, Martinez-Sobrido L, Zand MS, Sangster MY, Topham DJ. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins. PLoS One. 2017;12:e0188267. doi: 10.1371/journal.pone.0188267.
- Baillie JK, Paul D. Influenza-time to target the host? N Engl J Med. 2013;369:191–193. doi: 10.1056/NEJMcibr1304414.
- Mandal P, Roychowdhury S, Park PH, Pratt BT, Roger T, Nagy LE. Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. J Immunol. 2010;185:4928–4937. doi: 10.4049/jimmunol.1002060.
- Ma LL, Zhang P, Wang HQ, Li YF, Hu J, Jiang JD, Li YH. heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/β. Virol. 2019;528:80-88.
- Hill BL, Halfmann P, Neumann G, Kawaoka Y. The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. J Virol. 2013;87:13795–13802. doi: 10.1128/JVI.02422-13.
- Bunse CE, Fortmeier V, Tischer S. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses. Clin Exp Immunol. 2015;179:265–276. doi: 10.1111/cei.12451.
- Hossain MK, Saha SK, Abdal Dayem A. Bax Inhibitor-1 acts as an anti-influenza factor by inhibiting ROS mediated cell death and augmenting Heme-oxygenase 1 expression in influenza virus infected cells. Int J Mol Sci. 2018;19:712. doi: 10.3390/ijms19030712.
- Ma LL, Wang HQ, Wu P, Hu J, Yin JQ, Wu S, Ge M, Sun WF, Zhao JY, Aisa HA, Li YH, Jiang JD. Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response. Free Radic Biol Med. 2016;96:347–361. doi: 10.1016/j.freeradbiomed.2016.04.021.
- Cummins NW, Weaver EA, May SM. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J. 2012;26:2911–2918. doi: 10.1096/fj.11-190017.
- Yang L, Zhang SW, Liu ZQ, He JH, Rong XJ, Gu ZY XinJiang Medi University 2016; 5: 579.
- Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013;2013:162750.
- Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008;74:847–851. doi: 10.1055/s-2008-1074558.
- Serkedjieva J, Ivancheva S. Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L. J Ethnopharmacol. 1998;64:59–68. doi: 10.1016/S0378-8741(98)00095-6.
- Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T, Matsuse T, Ishigatubo Y. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 2001;8:1499–150720. doi: 10.1038/sj.gt.3301540.
- Choi AM, Knobil K, Otterbein SL, Eastman DA, Jacoby DB. Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation. Am J Phys. 1996;271:L383–L39121.
- Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557–256823. doi: 10.1096/fasebj.2.10.3290025.
- Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 1991;51:974–978.
- Jawed A, Daniel S, Cheri T, Sujji B, Augustine MK, Choi JL. Cook. Nrf2, a Cap’n’Collar transcription factor, regulates induction of the Heme Oxygenase-1 gene cell Microbiol. J Biol Chem. 1999;274:26071–26078. doi: 10.1074/jbc.274.37.26071.
- Maruyama A, Mimura J, Harada N, Itoh K. Nrf2 activation is associated with Z-DNA formation in the human HO-1 promoter. Nucleic Acids Res. 2013;41:5223–5234. doi: 10.1093/nar/gkt243.
- Wang B, Pakpour N, Napoli E. Anopheles stephensi p38 MAPK signaling regulates innate immunity and bioenergetics during plasmodium falciparum infection. Parasit Vectors. 2015;8:424. doi: 10.1186/s13071-015-1016-x.
- Taruna A, Georgia FS, Mark JE, Diane FJ. Dissociation between IFN-α-induced anti-viral and growth signaling pathways. J Immunol. 1999;162:3289–3297.
- Zhao M, Guo H, Chen J. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway. ajpcell. 2015;31:00369.
- Tzima S, Victoratos P, Kranidioti K, Alexiou M, Kollias G. Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J Exp Med. 2009;206:1167–1179. doi: 10.1084/jem.20081582.
- Tseng CK, Lin CK, Wu YH. Human heme oxygenase 1 is a potential host cell factor against dengue virus replication. Sci Rep. 2016;6:32176. doi: 10.1038/srep32176.
- Hull TD, Agarwal A, George JF. The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1. Antioxid Redox Signal. 2014;20:1770–1788. doi: 10.1089/ars.2013.5673.
- Kovacsics CE, Gill AJ, Ambegaokar SS, Gelman BB, Kolson DL. Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: a potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesis. Glia. 2017;65:1264–1277. doi: 10.1002/glia.23160.
- Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf2 expression modifies influenza a entry and replication in nasal epithelial cells. Free Radic Biol Med. 2011;51:444–453. doi: 10.1016/j.freeradbiomed.2011.04.027.
- Ibáñez FJ, Farías MA, Retamal-Díaz A, Espinoza JA, Kalergis AM, González PA. Pharmacological induction of Heme Oxygenase-1 impairs nuclear accumulation of herpes simplex virus capsids upon infection. Front Microbiol. 2017;8:2108. doi: 10.3389/fmicb.2017.02108.
- Anthony JS, Bryan RGW. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8:559–568. doi: 10.1038/nri2314.
- Traboulsi H, Cloutier A, Boyapelly K. The flavonoid Isoliquiritigenin reduces lung inflammation and mouse morbidity during influenza virus infection. Antimicrob Agents Chemother. 2015;59:6317–6327. doi: 10.1128/AAC.01098-15.
- Zhong M, Wang HQ, Yan HY, Wu S, Gu ZY, Li YH. Santin inhibits influenza a virus replication through regulating MAPKs and NF-κB pathways. J Asian Nat Prod Res. 2018;10:1–10. doi: 10.1080/10286020.2018.1520221.
Source: PubMed